Spots Global Cancer Trial Database for Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma
Official Title: Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma
Study ID: NCT04535687
Conditions
Interventions
Study Description
Brief Summary: This trial aims to prospectively assess the safety and efficiency of Fluzoparib in metastatic non-clear cell renal cell carcinoma
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
Contact Details
Name: Hongqian Guo, Phd
Affiliation: Department of Urology, Drum Tower Hospital, Medical School of Nanjing University
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
